JamesHenryLairdJrMD

PubMed

• Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiati...
  Nipun Verma, James H Laird, Nicholas S Moore, Thomas J Hayman, Nadine Housri, Gabrielle W Peters, Christin A Knowlton, Vikram Jairam, Allison M Campbell, Henry S Park> ;Advances in Radiation Oncology. 2024 Jun 1
• Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy.
  Alexander Sasse, Patrick Oh, Nadia Saeed, Daniel X Yang, Thomas J Hayman, Christin A Knowlton, Gabrielle W Peters, Allison Campbell, James Laird, Nadine Housri, Henry ...> ;Practical Radiation Oncology. 2023 Nov 19
• 3 citations
  Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Spe...
  Meriem Mokhtech, James H. Laird, Sean Maroongroge, Diana Zhu, Benjamin P. Falit, Peter A.S. Johnstone, Constantine Mantz, Ronald D. Ennis, Howard M. Sandler, Arie P. D...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Nov 1
• 10 citations
  Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Pa...
  James Laird, Benjamin H. Lok, Brandon Carney, Susanne Kossatz, Elisa de Stanchina, Thomas Reiner, John T. Poirier, Charles M. Rudin> ;Journal of Thoracic Oncology. 2019 Oct 1
• 28 citations
  Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.
  Jennifer Ma, James Laird, K. Chau, Monica Chelius, Benjamin H. Lok, Joachim Yahalom> ;Cancer Medicine. 2019 Jan 1
• Reply to "Questions About In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy".
  James Laird, Lior Z. Braunstein> ;Annals of Surgical Oncology. 2018 Nov 1
• 55 citations
  Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.
  James Laird, Benjamin H. Lok, Jennifer Ma, Andrew C. Bell, Elisa de Stanchina, John T. Poirier, Charles M. Rudin> ;Clinical Cancer Research. 2018 Oct 15
• ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.
  James Laird, Lior Z. Braunstein> ;Annals of Surgical Oncology. 2018 Oct 10
• 8 citations
  Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy
  James Laird, Benjamin H. Lok, Chun Siu, Oren Cahlon, Atif J. Khan, Beryl McCormick, Simon N. Powell, Hiram S. Cody, Hannah Yong Wen, Alice Y. Ho, Lior Z. Braunstein> ;Annals of Surgical Oncology. 2018 Jan 1
• 14 citations
  Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
  James Laird, Jennifer Ma, Karen Chau, Monica Chelius, Weiji Shi, Zhigang Zhang, Benjamin H. Lok, Joachim Yahalom> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Mar 1
• 291 citations
  Unravelling the biology of SCLC: implications for therapy
  Joshua K. Sabari, Benjamin H. Lok, James Laird, John T. Poirier, Charles M. Rudin> ;Nature Reviews. Clinical Oncology. 2017 May 23
• Join now to see all